Medical Sequencing at the extremes of Human Body Mass by Ahituv, Nadav et al.
Medical Sequencing at the Extremes of Human Body Mass 
 
Nadav Ahituv1,2, Nihan Kavaslar3, Wendy Schackwitz1,2, Anna Ustaszewska2, Joel Martin2, Sybil 
Hébert3, Heather Doelle3, Baran Ersoy4, Gregory Kryukov5, Steffen Schmidt5, Nir Yosef6, Eytan 
Ruppin6,7, Roded Sharan6, Christian Vaisse4, Shamil Sunyaev5, Robert Dent3, Jonathan Cohen8, Ruth 
McPherson3 and Len A. Pennacchio1,2,* 
 
1Genomics Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720 USA 
2U.S. Department of Energy Joint Genome Institute, Walnut Creek, California 94598 USA  
3Division of Cardiology and Lipoprotein & Atherosclerosis Research Group, University of Ottawa 
Heart Institute, Ottawa, K1Y 4W7, Canada 
4 Diabetes Center, University of California, San Francisco, California, USA. 
5Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical 
School, Boston, MA 02115, USA. 
6School of Computer Science, Tel-Aviv University, Tel-Aviv 69978, Israel. 
7School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel. 
8Center for Human Nutrition and McDermott Center for Human Growth and Development, University 
of Texas Southwestern Medical Center, Dallas, TX, USA. 
 
* To whom correspondence should be addressed: 
Len A. Pennacchio, Genomics Division, One Cyclotron Road, MS 84-171, Lawrence Berkeley 
National Laboratory, Berkeley, CA 94720.  Email: LAPennacchio@lbl.gov Phone: (510) 486-7498, 
Fax: (510) 486-4229. 
 2
 ABSTRACT 
 
Body weight is a quantitative trait with significant heritability in humans.  To identify potential genetic 
contributors to this phenotype, we resequenced the coding exons and splice junctions of 58 genes in 
379 obese and 378 lean individuals.  Our 96Mb survey included 21 genes associated with monogenic 
forms of obesity in humans or mice, as well as 37 genes that function in body weight-related pathways.  
We found that the monogenic obesity-associated gene group was enriched for rare nonsynonymous 
variants unique to the obese (n=46) versus lean (n=26) populations.  Computational analysis further 
predicted a significantly greater fraction of deleterious variants within the obese cohort.  Consistent 
with the complex inheritance of body weight, we did not observe obvious familial segregation in the 
majority of the 28 available kindreds.  Taken together, these data suggest that multiple rare alleles with 
variable penetrance contribute to obesity in the population and provide a deep medical sequencing-
based approach to detect them. 
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Obesity is reaching epidemic proportions in developed countries and represents a significant risk factor 
for hypertension, heart disease, diabetes, and dyslipidemia1.  While the growing prevalence of obesity 
in the population is thought to be caused by increasing caloric intake and declining energy 
expenditure2, individual susceptibility to obesity is strongly influenced by heredity.  Twin, adoption, 
and family studies have indicated that 40 to 70% of inter-individual variation in BMI is heritable 3,4.  In 
a limited number of cases, single gene defects have been linked to obesity 5, although the majority of 
cases are thought to be attributed to complex genetic and/or environmental interactions.  In this study, 
we sought to explore the relationship between sequence variation in multiple candidate genes and the 
extremes of human body mass. 
 
Candidate genes for the study included: (1) 21 genes that have been strongly associated with obesity, 
that when disrupted lead to monogenic forms of obesity in humans and/or that cause obesity when 
inactivated in mice, and (2) 37 genes involved in regulation of food intake 6, adipogenesis 7, energy 
expenditure 8 or lipid metabolism (Table 1).  The coding exons and splice junctions of each gene were 
sequenced in 379 extremely obese Caucasian men and women (mean BMI 49.0 kg/m2 and >95th 
percentile adjusted for age and sex) ascertained through an obesity clinic at the University of Ottawa, 
and in 378 lean (mean BMI 19.4 kg/m2 and <10th percentile adjusted for age and sex) apparently 
healthy Caucasians who participated in a study of leanness at the same institution (Supplementary 
Table S1).  A total of 134 kb (60 kb coding and 74 kb noncoding) was sequenced in each individual, 
representing 96 Mb of high quality sequence data with an average coverage of 734 individuals per 
exon (Table 2).  Cumulatively, we identified 1074 genetic variants (Supplementary table S2), 
averaging one variant per 125 bp of the reference human genome sequence.  252 of the variants were 
common polymorphisms (minor allele frequency >1%) while the remaining 822 rare variants included 
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400 noncoding, 150 synonymous, 272 nonsynonymous including 3 in-frame indels and 8 severe alleles 
(6 out of frame indels and 2 nonsense changes).  In accord with previous large-scale gene centric 
sequence analyses9-11, we observed a paucity of nonsynonymous variants with increasing minor allele 
frequency, consistent with purifying selection acting on a significant fraction of such DNA sequence 
changes (Figure 1).  Of the 1074 variants identified in this study, 989 (92%) were not listed in dbSNP 
(build 124) and as expected the majority of these variants (800/989, 81%) had a rare minor allele 
frequency (<1%). 
 
It has been previously reported that multiple rare variants can have a strong effect on complex traits, 
especially in the population extremes of a given phenotype12,13.  We therefore examined the 
frequencies of the nonsynonymous variants in the obese and lean cohorts.  Of the 272 rare 
nonsynonymous changes identified, 213 were unique to one group, with a small excess in the obese 
(n=118) compared to the lean population (n=95) that did not reach statistical significance.  A similar 
analysis revealed that the prevalence of unique rare synonymous variants, which approximate 
functionally neutral changes, was essentially identical in the obese and lean cohorts (60 in obese, 61 in 
lean).  We next examined the distributions of nonsynonymous and synonymous variants within each 
gene individually and found that none of the genes had a statistically significant excess of 
nonsynonymous variants in the obese or lean groups.  However, when the genes associated with 
monogenic forms of obesity were considered together, unique nonsynonymous variants were 
significantly more common in the obese (46 variants in 41 individuals) than in the lean group (26 
variants in 27 individuals) (P<0.05; Fisher’s exact test).  In contrast, the number of unique synonymous 
variants in these genes was almost identical among the obese (n=18) and lean (n=16) groups.  It is 
 5
worth noting that the genes that accounted for the highest difference are: MC4R (8 in obese versus 2 in 
lean), SIM1 (6 in obese versus 0 in lean), and UCP3 (5 in obese versus 2 in lean). 
 
The excess of nonsynonymous variants among obese individuals may reflect chance fluctuation in 
allele frequencies, population stratification, or the accumulation in this group of functional sequence 
variants that predispose individuals to obesity.  Chance fluctuation in allele frequencies seems 
unlikely, as the excess of nonsynonymous variants in the obese group was not due to an increased 
number of variants in any single gene, but rather to the cumulative contribution of variants at several 
unlinked loci.  Population stratification also seems improbable, as both groups comprised Caucasian 
men and women from the same region (Ottawa, Canada).  Furthermore, the number of synonymous 
variants (Table 1) and the allele frequencies of ~250 common sequence variants (see below) in these 
genes were similar in the obese and lean groups.  Therefore it seems likely that the excess of rare 
variants in the obese group represents the accumulation of functional alleles that contribute to the 
phenotype in these individuals. 
 
As a first step to assess the functional significance of the nonsynonymous sequence variants identified 
in the 21 genes associated with monogenic forms of obesity in humans and mice, we used the 
computer algorithm PolyPhen14 to predict the effects of amino acid substitutions on protein function.  
We observed that variants identified in the monogenic obesity gene group were more likely to be 
deleterious in the obese cohort than those identified in the lean cohort (19 in the obese versus 4 in the 
lean; P <0.002, exact binomial test; Figure 2).  In comparison, the number of benign (25 in the obese 
and 21in the lean) and synonymous (18 in the obese versus 16 in lean) variants in these genes was 
similar in both cohorts.  In contrast, the distribution of synonymous, benign, and deleterious alleles in 
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the 37 candidate genes not associated with monogenic forms of obesity was similar in the obese and 
lean groups.  This finding is consistent with the notion that the excess of nonsynonymous sequence 
variants in the obese cohort among the monogenic obesity group of genes reflects the accumulation of 
functional variants.   
 
Next we examined familial segregation for 28 rare variants identified in 14 genes (Table 3 & 
Supplementary Table S3) in obtainable obese kindreds, to determine whether nucleotide changes 
within these genes segregate with BMI.  We used MC4R as a test case, since it is the most common 
cause of monogenic obesity, estimated to account for 1-6% of severe obesity cases15.  In our study we 
identified 8 nonsynonymous variants that were unique to the obese group compared to only 2 in the 
lean cohort (Table 1).  We found that the mutant MC4R alleles clearly failed to segregate with obesity 
in three of the five kindreds, with 6 or more family members available (Table 3), including an allele 
with a previously characterized frame-shift mutation (L211 4bp deletion)16 that is almost certainly 
functional.  To corroborate that these MC4R variants were indeed functional, we performed established 
in vitro functional assays for the novel MC4R variants15 identified in our obese population.  Of the five 
putative mutations analyzed for segregation, four displayed impaired MC4R function (Table 3).  These 
findings are consistent with previous studies that also show incomplete correlation between MC4R 
mutations and obesity17,18 illustrating the difficulties inherent in determining the correspondence 
between genotype and phenotype in common, complex phenotypes such as obesity.  Although a 
number of the kindreds available for study were small, none of the other rare variants examined in 13 
additional genes showed significant segregation with BMI in a total of 21 kindreds with the exception 
of PYY Q62P, which we have previously reported19 (Supplementary Table S3). 
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While the goal of our study was not to perform an exhaustive genetic association study between 
common variants and BMI, we identified 252 polymorphisms with a frequency greater than 1% and 
examined their frequency distribution in the obese versus lean cohort (Supplementary table S2).  We 
found only 2 variants, DGAT1 rs6599571 and NTS rs1800832 (both in their gene’s respective 5’UTR; 
Supplementary Table S4), that displayed a significant frequency difference between the two 
populations.  In an attempt to replicate these findings, we compared their frequency in a second cohort 
of obese (n=382; mean BMI 38.6) and lean (n=381; mean BMI=20.8) subjects (Supplementary Table 
S1).  In both cases, we observed no difference in the allele frequencies between the second obese and 
lean cohorts, supporting that the initial observation was likely a false-positive discovery or limited to 
very extreme BMI phenotypes (Supplementary Table S4).  We should further note that none of the 38 
sequenced common variants that were previously examined for their association with BMI displayed a 
significant frequency difference between our original obese and lean groups (Supplementary Table 
S5).  Among them is the recently characterized rs7566605 SNP near INSIG2 20, that showed no 
difference in either of our obese/lean panels (Supplementary Table S5).  These results suggest that in 
this population, common variants within the coding regions and their proximal exon-intron junction in 
this subset of 58 genes are unlikely to contribute appreciably to extreme BMI susceptibility.  However, 
because we screened primarily the coding sequences and splice junctions of these genes, we can not 
exclude the possibility that common sequence variations in noncoding regions not sequenced in this 
study may have significant effects on BMI. 
 
Whereas the heritability of BMI has been firmly established, the identification of genes that contribute 
to obesity has proved challenging.  Resequencing of candidate genes selected on biological plausibility 
has in a few instances resulted in the identification of variants associated with obesity.  For instance, 
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the observation that Mc4r mouse knockouts are obese 21 led to the subsequent finding that mutations in 
this gene may lead to obesity in humans 16,22.  In this study we sought to use a similar approach using a 
large-scale sequencing strategy of numerous obesity candidate genes in two extreme BMI populations.  
We did not uncover a large number of novel genes associated with obesity, an endeavor that may have 
been obstructed by reasons ranging from a partial candidate gene list (n=58), a large but still limited 
collection of strictly Caucasian individuals (n=~380 in each group), sequencing mainly coding regions, 
and limited power and availability of subjects pedigrees.  However, we did identify several genes that 
warrant further investigations.  For instance, we observed a noteworthy rare nonsynonymous variant 
difference across the obese and lean cohorts in SIM1 (6 in obese versus 0 in lean) and PRKAG3 (10 in 
obese versus 4 in lean), suggesting that nonsynonymous variants within these genes may influence 
susceptibility to obesity.  SIM1 is of particular interest due to its strong biological plausibility including 
evidence that human chromosomal aberrations within the SIM1 region may lead to obesity23,24, the 
observation that Sim1 heterozygous null mice develop obesity25, and absence of reported obesity 
associated rare nonsyndromic variants.  In addition, we uncovered a significant difference between the 
total number of obese and lean nonsynonymous variants in previously characterized monogenic 
obesity genes, indicating that multiple rare variants may have an incomplete effect on this phenotype.  
Our familial segregation analysis demonstrated that even thoroughly characterized human monogenic 
obesity genes such as MC4R fail to show consistent linkage with BMI, further suggesting these 
variants exhibit variable penetrance.  While our analysis encompassed only a modest fraction of 
candidate BMI genes, it strengthens the hypothesis that the majority of genetic etiology governing 
obesity is complex and likely to be influenced by a combination of multiple susceptibility alleles, the 
majority of which are not independently causative of extreme BMI. 
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MATERIALS AND METHODS 
Subjects 
Obese Caucasian subjects were recruited from the patient population of the University of Ottawa 
Weight Management Clinic and the Heart Institute Lipid Clinic using previously reported criteria 19. 
Briefly, inclusion criteria included a BMI > 36 kg/m2 and a history of obesity for at least 10 years of 
adult life and no history of treatment with oral glucocorticoids, anti-psychotics, lithium or medical 
conditions including major depression, bipolar affective disorder or psychosis. Lean subjects of the 
same ethnic background, with a BMI < the 10th percentile for age and sex and no prior history of 
having had a BMI > 25th percentile for more than a 2 year consecutive period, were recruited from the 
Ottawa community (Supplementary Table S1). These subjects were excluded if they had any medical 
conditions affecting weight gain such as hypo- or hyper- thyroidism, eating disorders, major 
depression, or malabsorption syndromes. BMI for obese and lean subjects was categorized according 
to the population percentiles for age and sex using the Canadian Heart Health Survey data for subjects 
over the age of 18 years (data on file; Health Canada) and NHANES data for children 26. This study 
was approved by the institutional review boards of the University of Ottawa Heart Institute and the 
Ottawa Hospital and informed written consent was obtained from all participants. Genomic DNA was 
extracted from white blood cells by standard methods 27.  
 
Sequencing and data analysis 
Primers were designed to give a maximum product size of 500bp and a minimum of 40bp flanking the 
splice sites using the Exon Locator & eXtractor for Resequencing program (EXLR) 
(http://mutation.swmed.edu/ex-lax/). An M13F tag (gttttcccagtcacgacgttgta) and M13R tag 
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(aggaaacagctatgaccat) was added to forward and reverse primers respectively. 10ng of DNA from each 
sample was amplified in a 10ul PCR reaction using AmpliTaq Gold® (Applied Biosystems) and 
cleaned using the PCR product pre-sequencing kit (USB Corporation). Bidirectional sequencing was 
carried out using both M13 primers along with BigDye Terminator v3.1 Cycle Sequencing Kit 
(Applied Biosystems) (http://www.jgi.doe.gov/sequencing/protocols/archive/BigDye3.1auto1.0.doc) 
and cleaned with Tetra-Ethylene Glycol before separation on a 3730xl DNA Analyzer (ABI). Base 
calling, quality assessment and assembly were carried out using the Phred, Phrap, Polyphred, Consed 
software suite (www.phrap.org). All sequence variants identified were verified by manual inspection 
of the chromatograms and 156/157 (99%) nonsynonymous variants were positive for a second 
reverification using another independent sequencing reaction.  
 
PolyPhen analysis 
All coding SNPs were subdivided in groups of frameshift/nonsense variants, synonymous variants and 
missense variants.  Missense variants were further classified with respect to their potential impact on 
protein structure or function based on sequence conservation using a new version of the PolyPhen 
method14. PolyPhen relies on the analysis of multiple sequence alignments of homologous proteins 
together with functional annotation and structural information if available.  The new version of 
PolyPhen constructs multiple sequence alignment using a pipeline of several existing programs for 
aligning sequences, alignment quality control, and clustering of sequences.  Computational prediction 
methods are statistical in nature, and therefore, certain fractions of false-positive (~10%) and false-
negative (20%-30%) predictions are to be expected.  However, application of computational 
predictions increases power to detect difference in number of rare functional nonsynonymous variants 
in candidate genes between populations with different phenotypes. 
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MC4R functional analysis 
Cloning and functional studies of the MC4R mutations were performed as described previously 17,28,29 
Briefly, since MC4R is a single exon gene, mutated alleles were amplified and cloned directly from the 
genomic DNA of the patient. This also allowed for confirmation of the presence and the nature of the 
mutations. Human MC4R alleles were cloned into the pcDNA3 expression vector (Invitrogen) to 
express the native form and N-terminal Flag tagged and/or C-terminal V5His tagged form of the 
receptor. All expression vectors were sequenced to establish the presence of the mutation and the 
absence of PCR-induced mutations.  
 
For alpha-MSH activation studies, receptors were transiently transfected into a HEK293 cell line stably 
expressing luciferase under the control of a cAMP responsive promoter 28. Cells were split into 96 well 
plates 24 hour after transfection and, 36 hours post-transfection, washed and incubated in stimulation 
medium (MEM-alpha medium containing 0.1 mg/ml BSA and 0.25mM isobutylmethylxanthine) and 
stimulated with different concentrations of alpha-MSH (Sigma) for 6h at 37°C in a 5% CO2 incubator. 
Luciferase activity, representing cAMP produced in response to alpha-MSH, was assessed using the 
Steady-Glo Luciferase Assay System (Promega) and a microplate luminescence counter (Packard 
Instrument). Results were normalized to the maximal stimulation by 8Br-cAMP. Basal activity of the 
receptors were determined by transient co-transfection with the c-AMP dependent luciferase 
expressing plasmid. All experiments were normalized for transfection efficiency by co-transfection of 
a plasmid encoding the Renilla luciferase expression plasmid PRL RSV to control for transfection 
efficiency. Data were analyzed using the GraphPad Prism software (Graphpad Software). 
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Common variant statistical analysis 
Common SNPs were preprocessed to remove tri-allelic SNPs, and SNPs for which more than 50% of 
the data were missing. In addition we clustered together SNPs that differed in at most 3 individuals, 
picking one representative from each such cluster. Chi-square tests were applied for each of the 
remaining 252 SNPs based on a contingency table of genotype-phenotype frequencies.  The obtained 
p-values were adjusted for multiple SNP testing using the false discovery rate (FDR) procedure30. 
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FIGURE LEGENDS 
 
Figure 1.  The percentage of nonsynonymous, synonymous, and intronic variants for different minor 
allele frequencies.   
 
Figure 2.  PolyPhen distribution analysis of variants unique to the obese and lean cohorts. (a) Data 
presented for genes with evidence of monogenic involvement in obesity and (b) for genes with 
biological plausibility for a role in obesity. ** P <0.002. 
Table 1. A summary of rare coding variants unique to the obese or lean population. Genes were divided into 
(1) genes that have been strongly associated with obesity (Monogenic Obesity Genes) and (2) obesity 
candidate genes based on biological plausibility (Candidate Obesity Genes). References can be found in the 
supplementary material. NS=Nonsynonymous, S=Synonymous. 
Monogenic Obesity Genes 
Gene Mouse Knockouts Mouse 
Transgenics
Human 
Mutations
Associations 
(ref.) 
OBESE
NS    S 
LEAN
NS    S
ATGL Obese31 None None None 3 1 2 2
BRS3 Obese32 None None None 1 0 3 0
CART Obese33 None Obese34 35-37 1 1 0 1
FABP4 Obese38 None None 39 1 0 2 0
GPR7 Obese40 None None None 3 0 1 0
HTR2C Obese41 None None 42,43 1 0 0 0
IL6 Obese44 None None 45-51 0 1 0 0
LEPTIN Obese52 Lean53 Obese54 55-62 0 3 0 1
MC3R Obese63 None Obese64 65,66 2 0 1 1
MC4R Obese22 None Obese15 67-71 8 1 2 1
NHLH2 Obese72 None  None None 2 0 1 1
NMU Obese73 None None None 1 0 1 0
NPB Obese74 None  None None 1 0 2 0
NPY1R Obese75 None None None 1 1 2 1
NPY2R Obese76 None None 77-79 2 3 2 0
NPY5R Obese80 None None 81 1 1 1 0
NR0B2 No apparent phenotype82 None  Obese83,84 84-86 3 0 2 0
POMC Obese87 None Obese88 89-97 2 3 1 3
PYY Obese98 None Obese20 77-79,99 2 0 1 0
SIM1 Obese26 Lean100 Obese24,25 None 6 2 0 2
UCP3 No apparent phenotype101 Lean102 Obese103 104-115 5 1 2 3
TOTAL     46 18 26 16
Obesity Candidate Genes 
Gene Mouse 
KO 
Mouse 
Tg 
Human 
Mutations
Associations 
(ref.) 
OBESE
NS    S 
LEAN
NS    S
ACDC Insulin resistance116 None None 117-123 2 0 2 0
AGRP No apparent phenotype124 Obese125 None 126,127 1 1 0 2
APOA5 Hyperlipidemia128 Lipid128 None 129,130 1 0 2 1
ARNT2 Lethal131 None None None 2 2 3 0
ASIP No apparent phenotype132 Obese133 None None 0 0 0 0
C3AR1 Hypoallergic134  None None None 4 0 4 3
CCK No apparent phenotype135 None None None 0 0 1 0
CPT1B None None None None 5 2 7 2
CSF2 Pulmonary anomalies136 None None None 0 0 0 1
CTRP2 None None None None 1 2 0 2
DGAT1 Lean137 None None 138,139 5 3 2 2
DGAT2 Lean140 None None None 5 0 3 2
GHRL No apparent phenotype141 None None 142-145 1 0 0 1
GHSR No apparent phenotype146 None None 147-149 1 2 2 1
GPR8 None None None None 1 2 2 5
HSD11B1 Obesity resistance150 Obese151 None 152,153 0 1 1 0
HTR7 Hyperthermia154 None None None 1 2 1 3
INSIG1 None None None None 0 2 3 0
INSIG2 None None None None 1 2 2 1
LIPC Hyperlipidemia155 None None 156 4 5 2 7
NMUR1 None None None None 4 4 2 1
NMUR2 None None None None 4 0 3 0
NPY No apparent phenotype157 None None 158-161 0 0 0 0
NTS No apparent phenotype162 None None None 0 0 4 0
PPARGC1A Lean163 None None 164-169 3 1 4 1
PPY None Lean170 None None 0 0 1 0
PRKAA1 None None None None 3 1 4 0
PRKAA2 Reduced glucose tolerance 171 None None 172 4 2 3 1
PRKAB1 None None None 172 0 1 0 0
PRKAB2 None None None 172 2 0 1 0
PRKAG1 None None None None 0 1 0 1
PRKAG2 None None Heart173 None 2 0 1 2
PRKAG3 Impaired glycogen metabolism174 Glycogen174 None None 10 3 4 1
RETN Impaired gluconeogenesis175 Obese176 None 177-182 0 0 1 0
SIRT1 Increased insulin sensitivity183 None None None 3 2 1 4
TGFBR2 Impaired embryogenesis184 None None None 1 1 1 1
WDTC1 None None None None 1 0 2 0
TOTAL     72 42 69 45
 
Table 2. Sequencing summary. 
Genes 58 
Exons 324 
TOTAL genomic sequence covered (bp) 134,449 
Coding sequence 60,372 
Non-coding sequence 74,077 
TOTAL sequence scanned (bp) 96,059,368 
Coding sequence 44,254,489 
Non-coding sequence 51,804,879 
TOTAL variants 1,074 
Rare nonsynonymous variants 272 
Rare synonymous variants 150 
Rare non-coding variants 400 
Total rare variants 822 
Common nonsynonymous variants 43 
Common synonymous variants 44 
Common non-coding variants 165 
Total common variants 252 
Novel variants identified 989 
Known dbSNPs validated 85 
dbSNPs not validated 366 
 
Table 3. Characterization of MC4R nonsynonymous variants found in obese subjects. 
 
Variant 
Sequence N Known/ 
Novel 
Functional Studies Carriers Non-carriers 
    alpha-
MSH 
activation 
(EC50) 
Basal 
activity 
Summary genotyped 
       (n) 
BMI 
kg/m2 
mean 
(SD) 
genotyped 
       (n) 
BMI 
kg/m2 
mean 
(SD) 
P 
value
S30F tgagt[c/t]ccttg 1 Known185 Not tested alone28 Not tested Not tested 
G32E ccttg[g/a]aaaag 1 Novel 0.3nM 70% Minor 5 G/A 30.3 
(4.9) 
5 G/G 29.5 
(4.6) 
nsa 
E61K tgttg[g/a]agaat 1 Novel low  ≤10% Severe 3G/A 40.6 
(6.7) 
1G/G 31.2 - 
S127L tgact[c/t]ggtga 1 Known28 29nM 80% Intermediate 3C/T 37.1 
(4.3) 
3C/C 36.7 
(14.0) 
ns 
L211Delb 
 
ttct[ctct/-]atgt 2 Known16 Truncated receptor Severe - 
P299Hb cgatc[c/a]tctga 2 Known28 negative ≤10% Severe 
F1.2C/A 
& +/-    
F2.2C/A 
& +/- 
43.2 
(9.4) 
35.9 
(12.4) 
F1.4C/C 
& +/+ 
F2.5C/C 
& +/+ 
28.0 
(4.1) 
39.7 
(6.2) 
ns 
A303T tttat[g/a]cactc 1 Novel low ≤10% Severe 2G/A 35.8 
(mom) 
20.1c 
(child) 
4G/G 26.6 
(1.7) 
- 
C326R gcctt[t/c]gtgac 1 Novel 0.4nM 150% Minor 2T/C 30.2 
(1.7) 
1T/T 25.3 - 
WTd    0.3nM 100%       
185Reference appears in the supplementary references. 
a Not significant. 
bIndividuals who had the L211Del also had the P299H variant. 
c1.5 year old child, BMI >99% percentile. 
dWild-type. 
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